Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials

Status Not yet recruiting

Clinical Trial Summary

Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in bile duct cancer clinical trials, as well as the reasons for withdrawal or discontinuation. The insights gained from this study will ultimately benefit those with bile duct cancer who may be invited to participate in medical research in the years to come.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05706974
Study type	Observational
Source	Power Life Sciences Inc.
Contact	Michael B Gill
Phone	4159004227
Email	bask@withpower.com
Status	Not yet recruiting
Phase
Start date	February 2024
Completion date	February 2026

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04383210` - Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors	Phase 2
Recruiting	`NCT02954302` - Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy	N/A
Active, not recruiting	`NCT01954745` - A Phase II Study of Cabozantinib (XL-184) Monotherapy in Patients With Advanced Cholangiocarcinoma After Progression on First or Second Line Systemic Therapy	Phase 2
Recruiting	`NCT01439698` - Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry	N/A
Active, not recruiting	`NCT04164069` - Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab	Phase 1
Recruiting	`NCT05155878` - Prognostic Factors in Periampullary Tumors and Cysts
Recruiting	`NCT04993131` - Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma	N/A
Active, not recruiting	`NCT05662488` - FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy
Completed	`NCT05266300` - Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
Recruiting	`NCT04907643` - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	N/A
Active, not recruiting	`NCT04853017` - A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors	Phase 1
Recruiting	`NCT05286814` - M9241 in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma	Phase 2
Completed	`NCT02853474` - Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy	Phase 3
Completed	`NCT00639314` - Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy	N/A
Completed	`NCT04596865` - Recurrence After Whipple's (RAW) Study
Recruiting	`NCT05277766` - Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer	Phase 1
Recruiting	`NCT01522573` - T-EUS for Gastrointestinal Disorders: A Multicenter Registry	N/A
Enrolling by invitation	`NCT01111591` - Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer	Phase 4
Completed	`NCT00779688` - A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers	N/A
Active, not recruiting	`NCT04152018` - Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.	Phase 1